| 0 |
SLEEP DISORDER THERAPY |
81 |
0.4091 |
| 1 |
ANTACID THERAPY |
52 |
0.4000 |
| 2 |
ANALGESIC THERAPY |
81 |
0.2523 |
| 3 |
CONGENITAL HIATUS HERNIA |
55 |
0.2412 |
| 4 |
APPENDICOLITH |
92 |
0.2377 |
| 5 |
DRUG THERAPY |
79 |
0.2330 |
| 6 |
MALIGNANT MELANOMA STAGE 0 |
45 |
0.2153 |
| 7 |
ANTICOAGULANT THERAPY |
52 |
0.1831 |
| 8 |
BACTEROIDES INFECTION |
29 |
0.1111 |
| 9 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
48 |
0.0518 |
| 10 |
HYPERPHOSPHATAEMIA |
94 |
0.0437 |
| 11 |
BLOOD PHOSPHORUS INCREASED |
85 |
0.0311 |
| 12 |
TOTAL LUNG CAPACITY DECREASED |
35 |
0.0219 |
| 13 |
VASCULAR ACCESS SITE THROMBOSIS |
1 |
0.0200 |
| 14 |
VAGINAL FLATULENCE |
6 |
0.0198 |
| 15 |
PLEURITIC PAIN |
43 |
0.0156 |
| 16 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
78 |
0.0154 |
| 17 |
RESPIRATORY SYMPTOM |
41 |
0.0144 |
| 18 |
IRON DEFICIENCY |
63 |
0.0140 |
| 19 |
HYPOPHOSPHATAEMIA |
102 |
0.0138 |
| 20 |
BLOOD URIC ACID INCREASED |
78 |
0.0135 |
| 21 |
FEEDING PROBLEM IN NEWBORN |
1 |
0.0132 |
| 22 |
MYASTHENIA GRAVIS |
106 |
0.0131 |
| 23 |
LUNG OPACITY |
34 |
0.0129 |
| 24 |
AORTIC STENOSIS |
39 |
0.0112 |
| 25 |
VASCULAR ACCESS SITE INFECTION |
1 |
0.0104 |
| 26 |
APPENDICITIS |
93 |
0.0099 |
| 27 |
BREATH SOUNDS ABNORMAL |
45 |
0.0091 |
| 28 |
BENIGN PROSTATIC HYPERPLASIA |
47 |
0.0091 |
| 29 |
MICROEMBOLISM |
1 |
0.0088 |
| 30 |
TROPONIN INCREASED |
65 |
0.0085 |
| 31 |
VENTRICULAR FIBRILLATION |
93 |
0.0084 |
| 32 |
LARYNGITIS FUNGAL |
1 |
0.0078 |
| 33 |
BLOOD CALCIUM INCREASED |
62 |
0.0071 |
| 34 |
CARDIOGENIC SHOCK |
89 |
0.0062 |
| 35 |
BACTERIAL INFECTION |
104 |
0.0056 |
| 36 |
HYPERLIPIDAEMIA |
66 |
0.0055 |
| 37 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
92 |
0.0054 |
| 38 |
HYPERCHOLESTEROLAEMIA |
47 |
0.0049 |
| 39 |
NEURALGIA |
109 |
0.0045 |
| 40 |
ULCER |
71 |
0.0045 |
| 41 |
BLOOD TEST ABNORMAL |
62 |
0.0044 |
| 42 |
ASPIRATION |
48 |
0.0044 |
| 43 |
OLIGODIPSIA |
1 |
0.0043 |
| 44 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
117 |
0.0041 |
| 45 |
FULL BLOOD COUNT ABNORMAL |
43 |
0.0041 |
| 46 |
DRUG LABEL CONFUSION |
1 |
0.0040 |
| 47 |
GOUT |
70 |
0.0039 |
| 48 |
CHILD ABUSE |
1 |
0.0039 |
| 49 |
MICTURITION URGENCY |
44 |
0.0038 |
| 50 |
END STAGE RENAL DISEASE |
68 |
0.0037 |
| 51 |
RED BLOOD CELL SEDIMENTATION RATE |
1 |
0.0036 |
| 52 |
FEMALE GENITAL TRACT FISTULA |
6 |
0.0035 |
| 53 |
ASCITES |
94 |
0.0032 |
| 54 |
ADNEXAL TORSION |
1 |
0.0032 |
| 55 |
INFUSION |
1 |
0.0024 |
| 56 |
RALES |
14 |
0.0024 |
| 57 |
RADICULOPATHY |
6 |
0.0023 |
| 58 |
JOINT INJURY |
47 |
0.0022 |
| 59 |
RHONCHI |
3 |
0.0022 |
| 60 |
PROCTITIS |
6 |
0.0021 |
| 61 |
HYPONATRAEMIA |
118 |
0.0021 |
| 62 |
BRONCHIECTASIS |
14 |
0.0021 |
| 63 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
106 |
0.0020 |
| 64 |
TRANSAMINASES INCREASED |
45 |
0.0020 |
| 65 |
SPUTUM DISCOLOURED |
17 |
0.0018 |
| 66 |
BLOOD CHOLESTEROL INCREASED |
81 |
0.0017 |
| 67 |
SJOGREN'S SYNDROME |
1 |
0.0017 |
| 68 |
ACIDOSIS HYPERCHLORAEMIC |
1 |
0.0017 |
| 69 |
CARDIOVASCULAR DISORDER |
41 |
0.0016 |
| 70 |
PSOAS ABSCESS |
1 |
0.0016 |
| 71 |
CHRONIC SINUSITIS |
6 |
0.0016 |
| 72 |
OEDEMA GENITAL |
1 |
0.0016 |
| 73 |
BICYTOPENIA |
3 |
0.0015 |
| 74 |
CORONARY ARTERY DISEASE |
46 |
0.0015 |
| 75 |
IRON DEFICIENCY ANAEMIA |
14 |
0.0015 |
| 76 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
1 |
0.0015 |
| 77 |
SLEEP DISORDER |
104 |
0.0015 |
| 78 |
LOWER RESPIRATORY TRACT INFECTION |
66 |
0.0014 |
| 79 |
DIABETES MELLITUS |
110 |
0.0014 |
| 80 |
EYE ROLLING |
1 |
0.0014 |
| 81 |
INVESTIGATION ABNORMAL |
2 |
0.0014 |
| 82 |
OVARIAN MASS |
1 |
0.0014 |
| 83 |
BLOOD PARATHYROID HORMONE DECREASED |
2 |
0.0013 |
| 84 |
THROMBOSIS |
108 |
0.0013 |
| 85 |
ENTHESOPATHY |
2 |
0.0013 |
| 86 |
TRANSIENT ISCHAEMIC ATTACK |
43 |
0.0013 |
| 87 |
OBSTRUCTIVE AIRWAYS DISORDER |
14 |
0.0013 |
| 88 |
PNEUMONIA MYCOPLASMAL |
1 |
0.0013 |
| 89 |
HAEMOPERITONEUM |
1 |
0.0012 |
| 90 |
SWELLING |
116 |
0.0012 |
| 91 |
LIVER FUNCTION TEST INCREASED |
26 |
0.0012 |
| 92 |
INTENTIONAL PRODUCT MISUSE |
106 |
0.0012 |
| 93 |
MEAN PLATELET VOLUME DECREASED |
1 |
0.0012 |
| 94 |
DRY MOUTH |
91 |
0.0011 |
| 95 |
DRUG INTOLERANCE |
107 |
0.0011 |
| 96 |
GENERAL PHYSICAL HEALTH DETERIORATION |
126 |
0.0011 |
| 97 |
PULMONARY EMBOLISM |
103 |
0.0011 |
| 98 |
SEPSIS |
118 |
0.0011 |
| 99 |
UPPER RESPIRATORY TRACT INFECTION |
48 |
0.0010 |
| 100 |
BLOOD CREATININE INCREASED |
65 |
0.0010 |
| 101 |
ALANINE AMINOTRANSFERASE ABNORMAL |
2 |
0.0009 |
| 102 |
PULMONARY MASS |
14 |
0.0009 |
| 103 |
ABDOMINAL DISTENSION |
97 |
0.0009 |
| 104 |
HYPOVENTILATION |
3 |
0.0009 |
| 105 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 106 |
PROSTATE CANCER METASTATIC |
3 |
0.0009 |
| 107 |
HALO VISION |
1 |
0.0009 |
| 108 |
HYPOPNOEA |
3 |
0.0009 |
| 109 |
LIVER DISORDER |
38 |
0.0009 |
| 110 |
FEBRILE INFECTION |
1 |
0.0008 |
| 111 |
PANNICULITIS |
2 |
0.0008 |
| 112 |
MUSCULOSKELETAL STIFFNESS |
71 |
0.0008 |
| 113 |
MALIGNANT MELANOMA IN SITU |
1 |
0.0008 |
| 114 |
LUNG DISORDER |
39 |
0.0008 |
| 115 |
LUPUS VULGARIS |
1 |
0.0008 |
| 116 |
PULMONARY FIBROSIS |
15 |
0.0008 |
| 117 |
INCISIONAL HERNIA |
1 |
0.0007 |
| 118 |
HAEMOPTYSIS |
20 |
0.0007 |
| 119 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0007 |
| 120 |
SEBORRHOEIC KERATOSIS |
1 |
0.0007 |
| 121 |
URINARY TRACT DISORDER |
3 |
0.0007 |
| 122 |
PLEURAL EFFUSION |
40 |
0.0007 |
| 123 |
UMBILICAL HERNIA |
3 |
0.0006 |
| 124 |
ACUTE LEUKAEMIA |
1 |
0.0006 |
| 125 |
SOMNOLENCE |
122 |
0.0006 |
| 126 |
VAGINAL DISCHARGE |
6 |
0.0006 |
| 127 |
ANAEMIA |
113 |
0.0006 |
| 128 |
RETINITIS |
1 |
0.0006 |
| 129 |
GRANULOMA |
2 |
0.0006 |
| 130 |
ASPARTATE AMINOTRANSFERASE INCREASED |
29 |
0.0005 |
| 131 |
LYMPH NODE PAIN |
1 |
0.0005 |
| 132 |
OEDEMA PERIPHERAL |
65 |
0.0005 |
| 133 |
MACULAR DEGENERATION |
6 |
0.0005 |
| 134 |
GASTROINTESTINAL DISORDER |
45 |
0.0005 |
| 135 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
1 |
0.0005 |
| 136 |
C-REACTIVE PROTEIN ABNORMAL |
3 |
0.0005 |
| 137 |
ASTHMA |
52 |
0.0005 |
| 138 |
RENAL TUBULAR ACIDOSIS |
1 |
0.0005 |
| 139 |
POLYP |
3 |
0.0005 |
| 140 |
INFECTION SUSCEPTIBILITY INCREASED |
1 |
0.0005 |
| 141 |
ORAL CANDIDIASIS |
6 |
0.0005 |
| 142 |
RESPIRATORY RATE INCREASED |
4 |
0.0005 |
| 143 |
CONSTIPATION |
97 |
0.0004 |
| 144 |
SUSPECTED OFF LABEL USE |
2 |
0.0004 |
| 145 |
ABDOMINAL PAIN |
100 |
0.0004 |
| 146 |
CONDITION AGGRAVATED |
130 |
0.0004 |
| 147 |
OXYGEN CONSUMPTION INCREASED |
1 |
0.0004 |
| 148 |
PARAESTHESIA ORAL |
6 |
0.0004 |
| 149 |
BLOOD IMMUNOGLOBULIN E INCREASED |
1 |
0.0004 |
| 150 |
BLOOD PRESSURE DIASTOLIC DECREASED |
3 |
0.0004 |
| 151 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 152 |
HELICOBACTER INFECTION |
4 |
0.0004 |
| 153 |
BRONCHOPULMONARY ASPERGILLOSIS |
3 |
0.0004 |
| 154 |
HYPOXIA |
13 |
0.0004 |
| 155 |
HYPERTENSION |
77 |
0.0004 |
| 156 |
RHEUMATOID NODULE |
1 |
0.0004 |
| 157 |
TENOSYNOVITIS |
1 |
0.0004 |
| 158 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 159 |
SKIN HYPERTROPHY |
1 |
0.0004 |
| 160 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 161 |
RESPIRATORY RATE DECREASED |
1 |
0.0003 |
| 162 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 163 |
SWOLLEN JOINT COUNT INCREASED |
1 |
0.0003 |
| 164 |
HYPERREFLEXIA |
1 |
0.0003 |
| 165 |
BONE EROSION |
1 |
0.0003 |
| 166 |
PRODUCT USE IN UNAPPROVED INDICATION |
70 |
0.0003 |
| 167 |
FEAR OF INJECTION |
2 |
0.0003 |
| 168 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
3 |
0.0003 |
| 169 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
1 |
0.0003 |
| 170 |
TREMOR |
44 |
0.0003 |
| 171 |
AZOTAEMIA |
1 |
0.0003 |
| 172 |
DERMATITIS ALLERGIC |
3 |
0.0002 |
| 173 |
TENSION HEADACHE |
1 |
0.0002 |
| 174 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 175 |
RHEUMATIC FEVER |
1 |
0.0002 |
| 176 |
FREQUENT BOWEL MOVEMENTS |
6 |
0.0002 |
| 177 |
SYNOVITIS |
4 |
0.0002 |
| 178 |
WHEEZING |
13 |
0.0002 |
| 179 |
INCREASED TENDENCY TO BRUISE |
2 |
0.0002 |
| 180 |
PROCEDURAL PAIN |
6 |
0.0002 |
| 181 |
PERFORMANCE STATUS DECREASED |
1 |
0.0002 |
| 182 |
VOMITING |
100 |
0.0002 |
| 183 |
INFUSION RELATED REACTION |
14 |
0.0002 |
| 184 |
DRUG TOLERANCE |
1 |
0.0002 |
| 185 |
BODY TEMPERATURE INCREASED |
4 |
0.0002 |
| 186 |
SKIN NECROSIS |
1 |
0.0002 |
| 187 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 188 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 189 |
SUDDEN DEATH |
2 |
0.0002 |
| 190 |
RESPIRATORY TRACT CONGESTION |
3 |
0.0002 |
| 191 |
NYSTAGMUS |
1 |
0.0002 |
| 192 |
GASTROOESOPHAGEAL REFLUX DISEASE |
15 |
0.0002 |
| 193 |
METASTASES TO BONE |
3 |
0.0002 |
| 194 |
DEAFNESS UNILATERAL |
1 |
0.0002 |
| 195 |
RHEUMATOID FACTOR POSITIVE |
1 |
0.0002 |
| 196 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
31 |
0.0002 |
| 197 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 198 |
BLOOD IRON DECREASED |
2 |
0.0002 |
| 199 |
PRODUCT DOSE OMISSION ISSUE |
49 |
0.0002 |
| 200 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 201 |
CONTRAINDICATED PRODUCT ADMINISTERED |
5 |
0.0002 |
| 202 |
C-REACTIVE PROTEIN INCREASED |
6 |
0.0002 |
| 203 |
PYREXIA |
57 |
0.0002 |
| 204 |
FIBROMYALGIA |
4 |
0.0002 |
| 205 |
CYTOPENIA |
2 |
0.0002 |
| 206 |
HYPERCALCAEMIA |
2 |
0.0002 |
| 207 |
BLEPHAROSPASM |
1 |
0.0002 |
| 208 |
COLITIS |
6 |
0.0002 |
| 209 |
COLITIS ULCERATIVE |
7 |
0.0002 |
| 210 |
HEPATITIS |
4 |
0.0002 |
| 211 |
BREAST CANCER STAGE III |
1 |
0.0002 |
| 212 |
BLOOD PRESSURE SYSTOLIC INCREASED |
3 |
0.0002 |
| 213 |
MENINGITIS |
1 |
0.0001 |
| 214 |
OFF LABEL USE |
130 |
0.0001 |
| 215 |
DYSPNOEA |
84 |
0.0001 |
| 216 |
ULCER HAEMORRHAGE |
1 |
0.0001 |
| 217 |
ONYCHOCLASIS |
1 |
0.0001 |
| 218 |
RIGHT VENTRICULAR FAILURE |
1 |
0.0001 |
| 219 |
RECTAL HAEMORRHAGE |
6 |
0.0001 |
| 220 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
1 |
0.0001 |
| 221 |
TONGUE DISORDER |
1 |
0.0001 |
| 222 |
ASTHENIA |
51 |
0.0001 |
| 223 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 224 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 225 |
DUODENAL ULCER PERFORATION |
1 |
0.0001 |
| 226 |
HEART RATE IRREGULAR |
3 |
0.0001 |
| 227 |
DRUG DISPENSING ERROR |
2 |
0.0001 |
| 228 |
NAUSEA |
103 |
0.0001 |
| 229 |
BASAL CELL CARCINOMA |
2 |
0.0001 |
| 230 |
TORSADE DE POINTES |
1 |
0.0001 |
| 231 |
MUSCLE INJURY |
1 |
0.0001 |
| 232 |
PNEUMONIA |
39 |
0.0001 |
| 233 |
LIVE BIRTH |
1 |
0.0001 |
| 234 |
TYPE 2 DIABETES MELLITUS |
4 |
0.0001 |
| 235 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 236 |
HAEMATOMA |
3 |
0.0001 |
| 237 |
SKIN SWELLING |
1 |
0.0001 |
| 238 |
RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 239 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 240 |
DRUG ERUPTION |
2 |
0.0001 |
| 241 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
8 |
0.0001 |
| 242 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
5 |
0.0001 |
| 243 |
OSTEOMYELITIS |
2 |
0.0001 |
| 244 |
LUPUS-LIKE SYNDROME |
1 |
0.0001 |
| 245 |
EXOSTOSIS |
1 |
0.0001 |
| 246 |
HAEMATOCHEZIA |
6 |
0.0001 |
| 247 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 248 |
MUSCULOSKELETAL DISORDER |
2 |
0.0001 |
| 249 |
THROMBOTIC MICROANGIOPATHY |
1 |
0.0001 |
| 250 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 251 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 252 |
RESPIRATORY DISORDER |
3 |
0.0001 |
| 253 |
SLUGGISHNESS |
1 |
0.0001 |
| 254 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 255 |
PAIN |
59 |
0.0001 |
| 256 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 257 |
FOLLICULITIS |
1 |
0.0001 |
| 258 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 259 |
JOINT DISLOCATION |
1 |
0.0001 |
| 260 |
OSTEOARTHRITIS |
4 |
0.0001 |
| 261 |
HEADACHE |
59 |
0.0001 |
| 262 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 263 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 264 |
FOOT DEFORMITY |
1 |
0.0001 |
| 265 |
SKIN INFECTION |
1 |
0.0001 |
| 266 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 267 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 268 |
HYPERKALAEMIA |
3 |
0.0001 |
| 269 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 270 |
PRODUCTIVE COUGH |
4 |
0.0001 |
| 271 |
MOBILITY DECREASED |
6 |
0.0001 |
| 272 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
4 |
0.0001 |
| 273 |
ABDOMINAL PAIN UPPER |
17 |
0.0001 |
| 274 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 275 |
PEMPHIGUS |
1 |
0.0001 |
| 276 |
BRAIN OEDEMA |
1 |
0.0001 |
| 277 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 278 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 279 |
INFLAMMATION |
4 |
0.0001 |
| 280 |
SKIN ULCER |
2 |
0.0001 |
| 281 |
FATIGUE |
60 |
0.0001 |
| 282 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 283 |
HAND DEFORMITY |
1 |
0.0001 |
| 284 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 285 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 286 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 287 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 288 |
DISTURBANCE IN ATTENTION |
4 |
0.0001 |
| 289 |
TACHYPNOEA |
1 |
0.0001 |
| 290 |
DRUG TOXICITY |
1 |
0.0001 |
| 291 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 292 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 293 |
DYSPEPSIA |
7 |
0.0001 |
| 294 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 295 |
SINUSITIS |
7 |
0.0001 |
| 296 |
COUGH |
19 |
0.0001 |
| 297 |
DRUG INEFFECTIVE |
88 |
0.0001 |
| 298 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 299 |
EPILEPSY |
2 |
0.0001 |
| 300 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 301 |
TENDONITIS |
1 |
0.0001 |
| 302 |
LUNG INFECTION |
1 |
0.0001 |
| 303 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 304 |
METABOLIC ACIDOSIS |
2 |
0.0001 |
| 305 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 306 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 307 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 308 |
TREATMENT FAILURE |
5 |
0.0001 |
| 309 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 310 |
ABDOMINAL DISCOMFORT |
10 |
0.0001 |
| 311 |
PERICARDITIS |
1 |
0.0001 |
| 312 |
FACE OEDEMA |
1 |
0.0001 |
| 313 |
HEPATIC ENZYME INCREASED |
4 |
0.0001 |
| 314 |
INTENTIONAL PRODUCT USE ISSUE |
5 |
0.0001 |
| 315 |
ARTHROPATHY |
3 |
0.0001 |
| 316 |
MEDICATION ERROR |
3 |
0.0001 |
| 317 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 318 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 319 |
PROTEINURIA |
1 |
0.0001 |
| 320 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 321 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 322 |
EAR PAIN |
1 |
0.0001 |
| 323 |
SKIN FISSURES |
1 |
0.0001 |
| 324 |
DEATH |
44 |
0.0001 |
| 325 |
NASAL CONGESTION |
3 |
0.0001 |
| 326 |
DISABILITY |
1 |
0.0001 |
| 327 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 328 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 329 |
PREGNANCY |
1 |
0.0000 |
| 330 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 331 |
ILL-DEFINED DISORDER |
3 |
0.0000 |
| 332 |
PSORIATIC ARTHROPATHY |
2 |
0.0000 |
| 333 |
ALANINE AMINOTRANSFERASE INCREASED |
3 |
0.0000 |
| 334 |
CARDIO-RESPIRATORY ARREST |
2 |
0.0000 |
| 335 |
INTENTIONAL DRUG MISUSE |
1 |
0.0000 |
| 336 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 337 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 338 |
PERIPHERAL SWELLING |
7 |
0.0000 |
| 339 |
FEBRILE NEUTROPENIA |
3 |
0.0000 |
| 340 |
GLOSSODYNIA |
1 |
0.0000 |
| 341 |
ADVERSE DRUG REACTION |
4 |
0.0000 |
| 342 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 343 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 344 |
NEUTROPENIA |
6 |
0.0000 |
| 345 |
SHOCK |
1 |
0.0000 |
| 346 |
ADVERSE EVENT |
4 |
0.0000 |
| 347 |
HYPOKALAEMIA |
2 |
0.0000 |
| 348 |
HYPERSENSITIVITY |
8 |
0.0000 |
| 349 |
JOINT SWELLING |
5 |
0.0000 |
| 350 |
LOCALISED INFECTION |
1 |
0.0000 |
| 351 |
PRESYNCOPE |
1 |
0.0000 |
| 352 |
LIVER INJURY |
1 |
0.0000 |
| 353 |
AGGRESSION |
2 |
0.0000 |
| 354 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 355 |
CHEST DISCOMFORT |
4 |
0.0000 |
| 356 |
DRUG RESISTANCE |
1 |
0.0000 |
| 357 |
DIPLOPIA |
1 |
0.0000 |
| 358 |
ARTHRITIS |
3 |
0.0000 |
| 359 |
JOINT STIFFNESS |
1 |
0.0000 |
| 360 |
BRADYCARDIA |
2 |
0.0000 |
| 361 |
EAR INFECTION |
1 |
0.0000 |
| 362 |
JAUNDICE |
1 |
0.0000 |
| 363 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 364 |
OEDEMA |
2 |
0.0000 |
| 365 |
PALLOR |
1 |
0.0000 |
| 366 |
MOOD ALTERED |
1 |
0.0000 |
| 367 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 368 |
FEELING COLD |
1 |
0.0000 |
| 369 |
WOUND |
1 |
0.0000 |
| 370 |
ALOPECIA |
7 |
0.0000 |
| 371 |
RHEUMATOID ARTHRITIS |
4 |
0.0000 |
| 372 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 373 |
BONE PAIN |
2 |
0.0000 |
| 374 |
ERYTHEMA |
7 |
0.0000 |
| 375 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 376 |
HYPOAESTHESIA |
5 |
0.0000 |
| 377 |
HEPATIC FAILURE |
1 |
0.0000 |
| 378 |
DISCOMFORT |
2 |
0.0000 |
| 379 |
WEIGHT DECREASED |
9 |
0.0000 |
| 380 |
IMPAIRED HEALING |
1 |
0.0000 |
| 381 |
HEART RATE INCREASED |
3 |
0.0000 |
| 382 |
VIRAL INFECTION |
1 |
0.0000 |
| 383 |
URINARY RETENTION |
1 |
0.0000 |
| 384 |
GAIT INABILITY |
1 |
0.0000 |
| 385 |
MALAISE |
13 |
0.0000 |
| 386 |
MEMORY IMPAIRMENT |
4 |
0.0000 |
| 387 |
DELIRIUM |
1 |
0.0000 |
| 388 |
HEART RATE DECREASED |
1 |
0.0000 |
| 389 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 390 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 391 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 392 |
BRONCHITIS |
2 |
0.0000 |
| 393 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 394 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 395 |
DECREASED APPETITE |
6 |
0.0000 |
| 396 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 397 |
OSTEOPOROSIS |
1 |
0.0000 |
| 398 |
CARDIAC ARREST |
2 |
0.0000 |
| 399 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 400 |
MENTAL DISORDER |
1 |
0.0000 |
| 401 |
ANGIOEDEMA |
1 |
0.0000 |
| 402 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 403 |
NASOPHARYNGITIS |
4 |
0.0000 |
| 404 |
ARTHRALGIA |
9 |
0.0000 |
| 405 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 406 |
COMA |
1 |
0.0000 |
| 407 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 408 |
CONTUSION |
2 |
0.0000 |
| 409 |
DIZZINESS |
10 |
0.0000 |
| 410 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 411 |
NERVOUSNESS |
1 |
0.0000 |
| 412 |
ECZEMA |
1 |
0.0000 |
| 413 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 414 |
PANCREATITIS |
1 |
0.0000 |
| 415 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 416 |
RASH PRURITIC |
1 |
0.0000 |
| 417 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 418 |
INFLUENZA |
2 |
0.0000 |
| 419 |
NECK PAIN |
1 |
0.0000 |
| 420 |
BLISTER |
1 |
0.0000 |
| 421 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 422 |
EYE PAIN |
1 |
0.0000 |
| 423 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 424 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 425 |
CONVULSION |
1 |
0.0000 |
| 426 |
LETHARGY |
1 |
0.0000 |
| 427 |
FEELING ABNORMAL |
4 |
0.0000 |
| 428 |
IRRITABILITY |
1 |
0.0000 |
| 429 |
MUSCLE SPASMS |
3 |
0.0000 |
| 430 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 431 |
RASH |
7 |
0.0000 |
| 432 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 433 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 434 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 435 |
SWELLING FACE |
1 |
0.0000 |
| 436 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 437 |
INSOMNIA |
4 |
0.0000 |
| 438 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 439 |
VISION BLURRED |
2 |
0.0000 |
| 440 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 441 |
INJURY |
1 |
0.0000 |
| 442 |
ANXIETY |
4 |
0.0000 |
| 443 |
DIARRHOEA |
9 |
0.0000 |
| 444 |
HALLUCINATION |
1 |
0.0000 |
| 445 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 446 |
BACK PAIN |
3 |
0.0000 |
| 447 |
DRUG INTERACTION |
2 |
0.0000 |
| 448 |
CARDIAC FAILURE |
1 |
0.0000 |
| 449 |
DRUG ABUSE |
1 |
0.0000 |
| 450 |
URTICARIA |
2 |
0.0000 |
| 451 |
TACHYCARDIA |
1 |
0.0000 |
| 452 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 453 |
CARDIAC DISORDER |
1 |
0.0000 |
| 454 |
DYSPHAGIA |
1 |
0.0000 |
| 455 |
SYNCOPE |
1 |
0.0000 |
| 456 |
FLUSHING |
1 |
0.0000 |
| 457 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 458 |
ILLNESS |
1 |
0.0000 |
| 459 |
OVERDOSE |
2 |
0.0000 |
| 460 |
SEIZURE |
1 |
0.0000 |
| 461 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 462 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 463 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 464 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 465 |
HYPERHIDROSIS |
1 |
0.0000 |
| 466 |
PSORIASIS |
1 |
0.0000 |
| 467 |
RENAL FAILURE |
1 |
0.0000 |
| 468 |
DEHYDRATION |
1 |
0.0000 |
| 469 |
DRY SKIN |
1 |
0.0000 |
| 470 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 471 |
INFECTION |
1 |
0.0000 |
| 472 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 473 |
HOSPITALISATION |
1 |
0.0000 |
| 474 |
PARAESTHESIA |
1 |
0.0000 |
| 475 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 476 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 477 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 478 |
PRURITUS |
2 |
0.0000 |
| 479 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 480 |
WEIGHT INCREASED |
1 |
0.0000 |
| 481 |
DEPRESSION |
1 |
0.0000 |
| 482 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 483 |
FALL |
1 |
0.0000 |